EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Perceived barriers to cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: Results from a telephone survey

Susan Parker iD, Ashish A Deshmukh, Baojiang Chen, David R Lairson, Maria Daheri, Sally W Vernon, Jane R Montealegre

eLife · 26.05.2023 · 12

DOI: 10.7554/elife.84664 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift eLife, online erschienen am 26.05.2023. Verfasst von Susan Parker und 6 weiteren Autor:innen. Beteiligte Einrichtung: Baylor College of Medicine, Houston, United States. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, COVID-19. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, NCATS NIH HHS, National Institute for Minority Health and Health Disparities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Home-based self-sampling for human papillomavirus (HPV) testing may be an alternative for women not attending clinic-based cervical cancer screening.

Methods

We assessed barriers to care and motivators to use at-home HPV self-sampling kits during the COVID-19 pandemic as part of a randomized controlled trial evaluating kit effectiveness. Participants were women aged 30–65 and under-screened for cervical cancer in a safety-net healthcare system. We conducted telephone surveys in English/Spanish among a subgroup of trial participants, assessed differences between groups, and determined statistical significance at p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsCOVID-19HumansFemaleMaleHuman Papillomavirus VirusesEarly Detection of CancerPandemicsPapillomaviridaeSpecimen Handling

Stichwörter der Autor:innen

HPV self-samplingbarriers to careepidemiologyglobal healthhumanhuman papillomavirus

Autor:innen und Institutionen

  • Baylor College of Medicine, Houston, United States.
  • Medical University of South Carolina, Charleston, United States.
  • UTHealth School of Public Health, Houston, United States.
  • Harris Health System, Houston, United States.

ORCID-Profile: Susan Parker

Förderung

  • NIMHD NIH HHS
  • NCATS NIH HHS
  • National Institute for Minority Health and Health Disparities

Zitieren

APA

Parker, S., Deshmukh, A. A., Chen, B., Lairson, D. R., Daheri, M., Vernon, S. W., & Montealegre, J. R. (2023). Perceived barriers to cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: Results from a telephone survey. eLife, 12. https://doi.org/10.7554/elife.84664

Vancouver

Parker S, Deshmukh AA, Chen B, Lairson DR, Daheri M, Vernon SW, et al. Perceived barriers to cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: Results from a telephone survey. eLife. 2023;12. doi:10.7554/elife.84664

BibTeX
@article{Parker2023,
  author = {Parker, Susan and Deshmukh, Ashish A and Chen, Baojiang and Lairson, David R and Daheri, Maria and Vernon, Sally W and Montealegre, Jane R},
  title = {Perceived barriers to cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: Results from a telephone survey},
  journal = {eLife},
  year = {2023},
  volume = {12},
  doi = {10.7554/elife.84664}
}
Kostenlos starten →